1. South Korea Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

KKRX:373110
1,028.00
KRW
-18.00
(-1.72%)
-740.96EPS
20.77BMarket Cap

Latest Stock Split

Oct 01, 2025

628:553

For every 553 shares held, investors received 628. The price per share adjusted from $2785.00 to $2452.40.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Oct 01, 2025
    Before$2785.00
    Split ratio628:553
    After$2452.40
    Forward

About Xcell Therapeutics, Inc. stock splits

Xcell Therapeutics, Inc. (KRX:373110) operates in the Biotechnology industry.

Xcell Therapeutics, Inc. company overview

When did Xcell Therapeutics, Inc. stock split?

Xcell Therapeutics, Inc.'s most recent stock split was on October 1, 2025. It was a 628-for-553 forward split, so shareholders received 628 shares for every 553 they held.

How many times has Xcell Therapeutics, Inc. stock split?

Xcell Therapeutics, Inc. has split its stock once. This history records one forward split, on October 1, 2025.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Xcell Therapeutics, Inc.'s 628-for-553 split on October 1, 2025, every 553 shares became 628 shares.

Will Xcell Therapeutics, Inc. split its stock again?

Xcell Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on October 1, 2025, 1 year ago. Companies announce splits in advance, and any new KRX:373110 split will appear on this page.